Nephros Inc. reports developments in water technology for medical and commercial markets, with emphasis on point-of-use filtration, waterborne pathogen risk reduction, and water management support. Company news commonly covers quarterly financial results, programmatic revenue trends, service offerings, customer education, and product adoption across healthcare facilities and other complex buildings.
Updates also include expansions of Nephros' water safety capabilities, regional market initiatives, and the Nephros Water Institute, an education effort focused on water quality, infection prevention, regulatory readiness, and emergency preparedness for compromised water events.
Nephros, Inc. (Nasdaq: NEPH) has announced a change to its 2020 Annual Meeting of Stockholders, which will now be conducted via webcast on May 21, 2020, at 9:00 a.m. Eastern Time, due to public health concerns related to the coronavirus. Stockholders of record as of March 25, 2020, are encouraged to participate and vote online. After the meeting, management will provide business overviews and a Q&A session. Stockholders can submit questions through the virtual meeting platform.
Nephros reported a 43% increase in net revenue, reaching $2.5 million for Q1 2020, up from $1.8 million in Q1 2019. The company's net loss improved by 19%, totaling $1.1 million. Adjusted EBITDA showed a 7% improvement, at ($0.8 million). Gross margins increased to 59% from 56%. R&D expenses decreased by 26% to $0.6 million, while SG&A expenses rose by 30%, totaling $1.9 million. Nephros held $9.0 million in cash and equivalents as of March 31, 2020.
Summary not available.